Cuizon, Edraline .
HRN: 14-84-29 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/19/2023
CEFUROXIME 1.5GM (VIAL)
12/19/2023
12/20/2023
IV
1.5 G
Loading Dose
For Stat REPEAT CS For CPD
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes